Molecular structure of ionotropic glutamate receptors

Current Medicinal Chemistry

Volumn 17, Issue 24, 2010, Pages 2608-2635

  Kaczor, A A ^a   Matosiuk, D ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Gating of glutamate ion channels; Glutamate ion channel; LBD of ionotropic glutamate receptors; NTD of ionotropic glutamate receptors; Symmetry of ionotropic glutamate receptors

Indexed keywords

6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; [[3,4 DIHYDRO 7 MORPHOLINO 2,3 DIOXO 6 (TRIFLUOROMETHYL) 1(2H) QUINOXALINYL]METHYL]PHOSPHONIC ACID; AMPA RECEPTOR ANTAGONIST; ANIRACETAM; CONCANAVALIN A; CYCLOTHIAZIDE; IFENPRODIL; ION CHANNEL; IONOTROPIC RECEPTOR; KAINIC ACID RECEPTOR; N [2 [4 (3 THIENYL)PHENYL]PROPYL] 2 PROPANESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PIRACETAM; PROTEIN INTERACTING WITH PROTEIN KINASE C; TRAXOPRODIL;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHANNEL GATING; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; HUNTINGTON CHOREA; LIGAND BINDING; MAJOR DEPRESSION; MOLECULAR DOCKING; MOLECULAR MODEL; PARKINSON DISEASE; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; DRUG DESIGN; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; MODELS, MOLECULAR; PIPERIDINES; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IONOTROPIC GLUTAMATE;

EID: 77955599312     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791859379     Document Type: Article

References (245)

1. Kew, J.N.C.; Kemp, J.A. Ionotropic and metabotropic glutamate receptors - structure and pharmacology. Psychopharmacology, 2005, 179, 4-29.
2. Foster, A.C.; Kemp, J.A. Glutamate- and GABA-based CNS therapeutics. Curr. Opinion Pharmacol., 2006, 6, 7-17.
3. Chen, P.E.; Wyllie, D.J. Pharmacological insights obtained from structure-function studies of ionotropic glutamate receptors. Br. J. Pharmacol., 2006, 147, 839-853.
4. Planells-Cases, R.; Lerma, J.; Ferrer-Montiel, A. Pharmacological intervention at ionotropic glutamate receptor complexes. Curr. Pharm. Des., 2006, 12, 3583-3596.
5. Gordoni, F.; Di Luca, M. New targets for pharmacological intervention in the glutamatergic synapse. Eur. J. Pharmacol., 2006, 545, 2-10.
6. Platt, S.R. The role of glutamate in central nervous system health and disease - a review. Vet. J., 2007, 173, 278-286.
7. Bowie, D. Ionotropic glutamate receptors & CNS disorders. CNS Neurol. Disord. Drug Targets, 2008, 7, 129-143.
8. Johnson, K.A.; Conn, P.J.; Niswender, C.M. Glutamate receptors as therapeutic targets for Parkinson's disease. CNS Neurol. Disord. Drug Targets, 2009, 8, 475-491.
9. Marek, G.J.; Behl, B.; Bespalov, A.Y.; Gross, G.; Lee, Y.; Schoemaker, H. Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain? Mol. Pharmacol., 2010, 77, 317-326.
10. Collingridge, G.L.; Olsen, R.W.; Peters, J.; Spedding, M. A nomenclature for ligand-gated ion channels. Neuropharmacology, 2009, 56, 2-5.
11. Naur, P.; Hansen, K.B.; Kristensen, A.S.; Dravid, S.M.; Pickering, D.S.; Olsen, L.; Vestergaard, B.; Egebjerg, J.; Gajhede, M.; Traynelis, S.F.; Kastrup, J.S. Ionotropic glutamate-like receptor delta2 binds D-serine and glycine. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 14116-14121.
12. Schmid, S.M.; Hollmann, M. To gate or not to gate: are the delta subunits in the glutamate receptor family functional ion channels? Mol. Neurobiol., 2008, 37, 126-41.
13. Safferling, M.; Tichelaar, W.; Kummerle, G.; Joupilla, A.; Kuusinen, A.; Keinänen, K.; Madden, D.R. First images of glutamate receptor ion channel: oligomeric state and molecular dimensions of GluRB homomers. Biochemistry, 2001, 40, 13948-13953.
14. Tichelaar, W.; Safferling, M.; Keinänen, K.; Stark, H.; Madden, D.R. The three-dimensional structure of an ionotropic glutamate receptors reveals dimer of dimers assembly. J. Mol. Biol., 2004, 344, 435-442.
15. Nakagawa, T.; Cheng, Y.; Ramm, E.; Sheng, M.; Walz, T. Structure and different conformational states of native AMPA receptor complexes. Nature, 2005, 433, 545-549.
16. Nakagawa, T.; Cheng, Y.; Sheng, M.; Walz, T. Three-dimensional structure of an AMPA receptor without associated stargazin/TARP proteins. Biol. Chem., 2006, 387, 179-187.
17. Midgett, C.R.; Madden, D.R. The quaternary structure of a calcium- permeable AMPA receptor: conservation of shape and symmetry across functionally distinct subunit assemblies. J. Mol. Biol., 2008, 382, 578-584.
18. Kaczor, A.; Kijkowska-Murak, U.; Matosiuk, D. Theoretical studies on the structure and symmetry of the transmembrane region of glutamatergic GluR5 receptor. J. Med. Chem., 2008, 51, 3765- 3776.
19. Kaczor, A.; Kijkowska-Murak, U.; Kronbach, C.; Unverferth, K.; Matosiuk, D. Modeling of glutamate GluR6 receptor and its interactions with novel non-competitive antagonists. J. Chem. Inf. Model., 2009, 49, 1094-1104.
20. Jin, R.; Singh, S.K.; Gu, S.; Furukawa, H.; Sobolevsky, A.I.; Zhou, J.; Jin, Y.; Gouaux, E. Crystal structure and association behaviour of the GluR2 amino-terminal domain. EMBO J. 2009, 28, 1812- 1823.
21. Clayton, A.; Siebold, C.; Gilbert, R.J.; Sutton, G.C.; Harlos, K.; McIlhinney, R.A.; Jones, E.Y.; Aricescu, A.R. Crystal structure of the GluR2 amino-terminal domain provides insights into the architecture and assembly of ionotropic glutamate receptors. J. Mol. Biol., 2009, 392, 1125-1132.
22. Kumar, J.; Schuck, P.; Jin, R.; Mayer, M.L. The N-terminal domain of GluR6-subtype glutamate receptor ion channels. Nat. Struct. Mol. Biol., 2009, 16, 631-638.
23. Karakas, E.; Simorowski, N.; Furukawa, H. Structure of the zincbound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J., 2009, 28, 3910-3920.
24. Sobolevsky, A.I; Rosconi, M.P.; Gouaux, E. X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature, 2009, 462, 745-758.
25. Kasai, N.; Ramanujan, C.S.; Fujimoto, I.; Shimada, A.; Ryan, J.F.; Torimitsu, K. AFM observation of single, functioning ionotropic glutamate receptors reconstituted in lipid bilayers. Biochim. Biophys. Acta, 2010, in press [Epub ahead of print].
26. Mayer, M.L. Glutamate receptors at atomic resolution. Nature, 2006, 440, 456-462.
27. Oswald, R.E.; Ahmed, A.; Fenwick, M.K.; Loh, A.P. Structure of glutamate receptors. Curr. Drug Targets, 2007, 8, 573-582.
28. Simon, A.; Bencsura, A.; Palló, A.; Héja, L.; Kardos, J. Emerging the role of the structure of brain membrane targets recognizing glutamate. Curr. Drug Discov. Technol., 2008, 5, 70-74.
29. Capener, C.E.; Kim, H.J.; Arinaminpathy, Y.; Sansom, M.S.P. Ion channels: structural bioinformatics and modelling. Hum. Mol. Gen., 2002, 11, 2425-2433.
30. Tikhonov, D.B. Ion channels of glutamate receptors: structural modeling. Mol. Membr. Biol., 2007, 24, 135-147.
31. Sutcliffe, M.J.; Wo, Z.G.; Oswald, R.E. Three-dimensional model of non-NMDA glutamate receptor. Biophys. J., 1996, 70, 1577- 1589.
32. Tikhonov, D.B.; Magazanik, L.G. Origin and molecular evolution of ionotropic glutamate receptors. Neurosci. Behav. Physiol., 2009, 39, 763-773.
33. Cui, C.; Mayer, M.L. Heteromeric kainate receptors formed by the coassembly of GluR5, GluR6 and GluR7. J. Neurosci., 1999, 19, 8281-8291.
34. Paoletti, P.; Neyton, J. NMDA receptor subunits: function and pharmacology. Curr. Opin. Pharmacol., 2007, 7, 39-47.
35. Köhr, G.; NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res., 2006, 326, 439-446.
36. Atlason, P.T.; Garside, M.L.; Meddows, E.; Whiting, P.; McIlhinney, R.A. N-Methyl-D-aspartate (NMDA) receptor subunit NR1 forms the substrate for oligomeric assembly of the NMDA receptor. J. Biol. Chem., 2007, 282, 25299-25307.
37. Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S.F. The glutamate receptor ion channels. Pharmacol. Rev., 1999, 51, 7-61.
38. Sasaki, Y.F.; Rothe, T.; Premkumar, L.S.; Das, S.; Cui, J.; Talantova, M.V.; Wong, H.K.; Gong, X.; Chan, S.F.; Zhang, D.; Nakanishi, N.; Sucher, N.J.; Lipton, S.A. Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J. Neurophysiol., 2002, 87, 2052-63.
39. Cavara, N.A.; Hollmann, M. Shuffling the deck anew: how NR3 tweaks NMDA receptor function. Mol. Neurobiol., 2008, 38, 16- 26.
40. Kim, K.S.; Yan, D.; Tomita, S. Assembly and stoichiometry of the AMPA receptor and transmembrane AMPA receptor regulatory protein complex. J. Neurosci., 2010, 30, 1064-1072.
41. Greger, I.H.; Khatri, L.; Kong, F.; Ziff, E.B. AMPA receptor tetramerization is mediated by Q/R editing. Neuron, 2003, 40, 763- 774.
42. Greger, I.H.; Ziff, E.B.; Penn, A.C. Molecular determinants of AMPA receptor subunit assembly. Trends Neurosci., 2007, 30, 407-416.
43. Leenscher, W.D.; Hoch, W. Subtype specific assembly of alphaamino- 3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunits is mediated by their N-terminal domain. J. Biol. Chem., 1999, 274, 16907-16916.
44. Hollmann, M.; Heinemann, S. Cloned glutamate receptors. Annu. Rev. Neurosci., 1994, 17, 31-108.
45. Schiffer, H.H.; Swanson, G.T.; Heinemann, S.F. Rat GluR7 and a carboxy-terminal splice variant GluR7b are functional kainate receptor subunits with a low sensitivity to glutamate. Neuron, 1997, 19, 1141-1146.
46. Werner, P.; Voigt, M.; Keinänen, K.; Wisden, W.; Seeburg, P.H. Cloning of a putative high-affinity kainate receptors expressed predominantly in hipocampal CA3 cells. Nature, 1991, 351, 742-744.
47. Herb, A.; Burnasher, N.; Werner, P.; Sakman, B.; Wisden, W.; Seeburg, P.H. The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits. Neuron, 1992, 8, 775-85.
48. Barnard, E.A. Ionotropic glutamate receptors: new types and concepts. Trends Pharmacol. Sci., 1997, 18, 141-148.
49. O'Hara, P.J.; Sheppard, P.O.; Thogersen, H.; Venezia, D.; Haldeman, B.A.; McGrane, V.; Houmed, K.M.; Thomsen, C.; Gilbert, T.L.; Mulvihill, E.R. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron, 1993, 11, 41-52.
50. Paas, Y. The macro- and microarchitectures of the ligand-binding domain of glutamate receptors. Trends Neurosci., 1998, 21, 117- 125.
51. Fukami-Kobayaski, K.; Tateno, Y.; Nishikawa, K. Domain dislocation: a change of core structure in periplasmic binding proteins in their evolutionary history. J. Mol. Biol., 1999, 286, 279-290.
52. De Luca, L.; Macchiarulo, A.; Constantino, G.; Barreca, M.L.; Gitto, R.; Chimirri, A.; Pellicciari, R. Binding modes of noncompetitive AMPA antagonists: a computational approach. Il Farmaco, 2003, 58, 107-113.
53. Sach, J.S.; Saper, M.A.; Quiocho, F.A. Periplasmic binding protein structure and function. Refined X-ray structures of the leucine/isoleucine/valine binding protein in complex with leucine. J. Mol. Biol., 1989, 206, 171-191.
54. Trakhanov, S.D.; Vyas, N.K.; Luecke, H.; Kristensen, D.M.; Ma, J.; Quiocho, F.A. Ligand-free and -bound structures of the binding protein (LIVJ) of the Escherichia coli ABC leucine/isoleucine/ valine transport system: trajectory and dynamics of the interdomain rotation and ligand specificity. Biochemistry, 2005, 44, 6597-6608.
55. Kunishama, N.; Shimada, Y.; Tsuji, Y.; Sato, T.; Yamamoto, M.; Kumasaka, T.; Nakanishi, S.; Jingami, H.; Morikawa, K. Structural basis of glutamate recognition by a dimeric glutamate receptor. Nature, 2000, 407, 971-977.
56. 3+. Proc. Natl. Acad. Sci. U.S.A., 2002, 99, 2660-2665.
57. Dobrovetsky, E.; Khutoreskaya, G.; Seitova, A.; Cossar, D.; Edwards, A.M.; Arrowsmith, C.H.; Bountra, C.; Weigelt, J.; Bochkarev, A. Unpublished results.
58. Muto, T.; Tsuchiya, D.; Morikawa, K.; Jingami, H. Structures of the extracellular regions of the group II/III metabotropic glutamate receptors. Proc. Natl. Acad. Sci. U.S.A., 2007, 104, 3759-3764.
59. Sussman, J.L.; Abola, E.E.; Lin, D.; Jiang, J.; Manning, N.O.; Prilusky, J. The protein data bank. Bridging the gap between the sequence and 3D structure world. Genetica, 1999, 106, 149-158.
60. Matsuda, S.; Kamiya, Y.; Yuzaki, M. Roles of N-terminal domain on the function and quaternary structure of the ionotrpic glutamate receptor. J. Biol. Chem., 2005, 280, 20021-20029.
61. Marinelli, L.; Cosconati, S.; Steinbrecher, T.; Limongelli, V.; Bertamino, V.; Novellino, E.; Case, D.A. Homology modeling of NR2B modulatory domain of NMDA receptor and analysis of ifenprodil binding. ChemMedChem, 2007, 2, 1498-1510.
62. Meddows, E.; Le Bourdelles, B.; Grimwood, S.; Wafford, K.; Sandhu, S.; Whiting, P.; McIlhinney, R.A. Identification of molecular determinants that are important in the assembly of Nmethyl- D-aspartate receptors. J. Biol. Chem., 2001, 276, 18795- 18803.
63. Papadakis, M.; Hawkins, L.M.; Stephenson, F.A. Appropriate NR1-NR1 disulfide-linked homodimer formation is requisite for efficient expression of functional, cell surface N-methyl-D-aspartate NR1/NR2 receptors. J. Biol. Chem., 2004, 279, 14703-14712.
64. Ayalon, G.; Segev, E.; Elgavish, S.; Stern-Bach, Y. Two regions in the N-terminal domain of ionotropic glutamate receptor 3 form the subunit oligomerization interfaces that control subunit-specific receptor assembly. J. Biol. Chem., 2005, 280, 15053-15060.
65. Qiu, S.; Hua, Y.; Yang, F.; Chen, Y.; Luo, J. Subunit assembly of N-methyl-D-aspartate receptors analyzed by fluorescence resonance energy transfer. J. Biol. Chem., 2005, 280, 24923-24930.
66. Zheng, F.; Erreger, K.; Low, C.M.; Banke, T.; Lee, C.J.; Conn, P.J.; Traynelis, S.F. Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Nat. Neurosci., 2001, 4, 894-901.
67. Huggins, D.J.; Grant, G.H. The function of the amino-terminal domain in NMDA receptor modulation, J. Mol. Graph. Model., 2005, 23, 381-388.
68. Ng, F.M.; Geballe, M.T.; Snyder, J.P.; Traynelis, S.F.; Low, C.M. Structural insights into phenylethanolamines high-affinity binding site in NR2B from binding and molecular modeling studies. Mol. Brain, 2008, 1, 16-26.
69. Papadakis, M.; Hawkins, L.M.; Stephenson, F.A. Appropriate NR1-NR1 disulfide-linked homodimer formation is requisite for efficient expression of functional, cell surface N-methyl-D-aspartate NR1/NR2 receptors. J. Biol. Chem., 2004, 279, 14703-14712.
70. Mony, L.; Kew, J.N.C.; Gunthorpe, M.J.; Paoletti, P. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Br. J. Pharmacol., 2009, 157, 1301-1317.
71. Mony, L.; Krzaczkowski, L.; Leonetti, M.; Goff, A.L.; Alarcon, K.; Neyton, J.; Bertrand, H.O.; Acher, F.; Paoletti, P. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors. Mol. Pharmacol., 2009, 75, 60-74.
72. Tygesen, C.K.; Jorgensen, M.; Andersen, P.M. The importance of the two specific domains in ligand binding to the AMPA/kainate glutamate receptors GluR2 and GluR6. FEBS Lett., 1995, 363, 184- 188.
73. Herin, G.A.; Aizenman, E. Amino terminal domain regulation of NMDA receptor function. Eur. J. Pharmacol., 2004, 500, 101-111.
74. Paoletti, P.; Perin-Dureau, F.; Fayyazuddin, A.; Le Goff, A.; Callebaut, I.; Neyton, J. Molecular organization of a zinc-binding Nterminal modulatory domain in a NMDA receptor subunit. Neuron, 2000, 28, 911-925.
75. Rachline, J.; Perin-Dureau, F.; Le Goff, A.; Neyton, J.; Paoletti, P. The micromolar zinc-binding domain on the NMDA receptor subunit NR2B. J. Neurosci., 2005, 25, 308-317.
76. Perin-Dureau, F.; Rachline, J.; Neyton, J.; Paoletti, P. Mapping the binding site of the neuroprotective ifenprodil on NMDA receptors. J. Neurosci., 2002, 22, 5955-5965.
77. Malherbe, P.; Mutel, V.; Broger, C.; Perin-Dureau, F.; Kemp, J.A.; Neyton, J.; Paoletti, P.; Kew, J.N. Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket. J. Pharmacol. Exp. Ther., 2003, 307, 897-905.
78. Ng, F.M.; Geballe, M.T.; Snyder, J.P.; Traynelis, S.F.; Low, C.M. Structural insights into phenylethanolamines high-affinity binding site in NR2B from binding and molecular modeling studies. Mol. Brain, 2008, 1, 16-26.
79. Traynelis, S.F.; Hartley, M.; Heinemann, S.F. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science, 1995, 268, 873-876.
80. Low, C.M.; Lyuboslavsky, P.; French, A.; Le, P.; Wyatte, K.; Thiel, W.H.; Marchan, E.M.; Igarashi, K.; Kashiwagi, K.; Gernert, K.; Williams, K.; Traynelis, S.F.; Zheng, F. Molecular determinants of proton-sensitive N-methyl-D-aspartate receptor gating. Mol. Pharmacol., 2003, 63, 1212-1222.
81. Masuko, T.; Kashiwagi, K.; Kuno, T.; Nguyen, N.D.; Pahk, A.J.; Fukuchi, J.; Igarashi, K.; Williams, K. A regulatory domain (R1- R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein. Mol. Pharmacol., 1995, 55, 557-569.
82. Hatton, C.J.; Paoletti, P. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron, 2005, 46, 261- 274.
83. Madry, C.; Mesic, I.; Betz, H.; Laube, B. The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors. Mol. Pharmacol., 2007, 72, 1535-1544.
84. Marinelli, L.; Cosconati, S.; Steinbrecher, T.; Limongelli, V.; Bertamino, V.; Novellino, E.; Case, D.A. Homology modeling of NR2B modulatory domain of NMDA receptor and analysis of ifenprodil binding. ChemMedChem, 2007, 2, 1498-1510.
85. Gielen, M.; Le Goff, A.; Stroebel, D.; Johnson, J.W.; Neyton, J.; Paoletti, P. Structural rearrangements of NR1/NR2A NMDA receptors during allosteric inhibition. Neuron, 2008, 57, 80-93.
86. Balannik, V.; Menniti, F.S.; Paternain, A.V.; Lerma, J.; Stern-Bach, Y. Molecular mechanism of AMPA receptor noncompetitive antagonism. Neuron, 2005, 48, 279-288.
87. Ihle, E.C.; Patneau, D.K. Modulation of α-amino-3-hydroxy-5- methyl-4-isoxazolepropionic acid receptor desensitization by extracellular protons. Mol. Pharmacol., 2000, 58, 1204-1212.
88. Ayalon, G.; Stern-Bach, Y. Functional assembly of AMPA and kainate receptors is mediated by several discrete protein-protein interactions. Neuron, 2001, 31, 103-113.
89. Mansour, M.; Nagarajan, N.; Nehring, R.B.; Clements, J.D.; Rosenmund, C. Heteromeric AMPA receptors assemble with a preferred subunit stoichiometry and spatial arrangement. Neuron, 2001, 32, 841-853.
90. Kuusinen, A.; Abele, R.; Madden, D.R.; Keinänen, K. Oligomerization and ligand-binding properties of the ectodomain of the alpha- amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunit GluRD. J. Biol. Chem., 1999, 274, 28937-28943.
91. Madden, D.R. The structure and function of glutamate receptor ion channels. Nat. Rev. Neurosci., 2002, 3, 91-101.
92. Ayalon, G.; Segev, E.; Elgavish, S.; Stern-Bach, Y. Two regions in the N-terminal domain of ionotropic glutamate receptor 3 form the subunit oligomerization interfaces that control subunit-specific receptor assembly. J. Biol. Chem., 2005, 280, 15053-15060.
93. Matsuda, S.; Kamiya, Y.; Yuzaki, M. Roles of N-terminal domain on the function and quaternary structure of the ionotrpic glutamate receptor. J. Biol. Chem., 2005, 280, 20021-20029.
94. Uemura, T.; Mishina, M. The amino-terminal domain of glutamate receptor delta2 triggers presynaptic differentiation. Biochem. Biophys. Res. Commun., 2008, 377, 1315-1319.
95. Qiu, S.; Hua, Y.; Yang, F.; Chen, Y.; Luo, J. Subunit assembly of N-methyl-D-aspartate receptors analyzed by fluorescence resonance energy transfer. J. Biol. Chem., 2005, 280, 24923-30.
96. Zheng, F.; Erreger, K.; Low, C.M.; Banke, T.; Lee, C.J.; Conn, P.J.; Traynelis, S.F. Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Nat. Neurosci., 2001, 4, 894-901.
97. Tikhonova, I.G.; Baskin, I.I.; Palyulin, V.A.; Zefirov, N.S. Molecular modeling of N-terminal domains of NMDA-receptor. Study of ligand binding to N-terminal domains. Dokl. Biochem. Biophys., 2004, 397, 242-250.
98. Goaux E. Structure and function of AMPA receptors. J. Physiol., 2004, 554, 249-253.
99. Mayer, M.L.; Armstrong, N. Structure and function of glutamate receptor ion channels. Annu. Rev. Physiol., 2004, 66, 161-181.
100. Mayer, M.L. Glutamate receptor ion channels. Curr. Opin. Neurobiol., 2005, 15, 282-288.
101. Chen, P.E.; Wyllie, D.J.A. Pharmacological insight obtained from structure-function studies of ionotropic glutamate receptors. British J. Pharmacol., 2006, 147, 839-853.
102. Stern-Bach, Y.; Bettler, B.; Hartley, M.; Sheppard, P.O.; O'Hara, P.J.; Heinemann, S.F. Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins. Neuron, 1994, 13, 1345-1357.
103. Paas, Y.; Eisenstein, M.; Medevielle, F.; Teichberg, V.I.; Devillers-Thiéry, A. Identification of the amino acid subsets accounting for the ligand binding specificity of a glutamate receptor. Neuron, 1996, 17, 979-990.
104. Laube, B.; Hirai, H.; Sturgess, M.; Betz, H.; Kuhse, J. Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron, 1997, 18, 493-503.
105. Swanson, G.T.; Gereau, R.W.; Green, T.; Heinemann, S.F. Identification of amino acid residues that control functional behavior in GluR5 and GluR6 kainate receptors. Neuron, 1997, 19, 913-926.
106. Lampinen, M.; Pentikäinen, O.; Johnson, M.S.; Keinänen, K. AMPA receptors and bacterial periplasmic amino acid-binding proteins share the ionic mechanism of ligand recognition. EMBO J., 1998, 17, 4704-4711.
107. Stern-Bach, Y.; Russo, S.; Neuman, M.; Rosenmund, C. A point mutation in the glutamate binding site blocks desensitization of AMPA receptors. Neuron, 1998, 21, 907-918.
108. Sutcliffe, M.J.; Smeeton, A.H.; Wo, Z.G.; Oswald, R.E. Molecular modeling of ligand-gated ion channels. Methods Enzymol., 1998, 293, 589-620.
109. Paas, Y.; Devillers-Thiéry, A.; Teichberg, V.I.; Changeux, J.-P.; Eisenstein, M. How well can molecular modelling predict the crystal structure: the ligand-binding of glutamate receptors. Trends Pharm. Sci., 2000, 21, 87-92.
110. Inanobe, A.; Furukawa, H.; Gouaux, E. Mechanism of partial agonist action at the NR1 subunit of NMDA receptors. Neuron, 2005, 47, 71-84.
111. Furukawa, H.; Singh, S.K.; Mancusso, R.; Gouaux, E. Subunit arrangement and function in NMDA receptors. Nature, 2005, 438, 185-192.
112. Yao, Y.; Harrison, C.B.; Freddolino, P.L.; Schulten, K.; Mayer, M.L. Molecular mechanism of ligand recognition by NR3 subtype glutamate receptors. EMBO J., 2008, 27, 2158-2170.
113. Lum, M.-L.; Hogner, A.; Stensbol, T.B.; Gouaux, E.; Egebjerg, J.; Kastrop, J.S. Three-dimensional structure of the ligand-binding core of GluR2 in complex with the agonist (S)-ATPA: implications for receptor subunit selectivity. J. Med. Chem., 2003, 46, 872-875.
114. Holm, M.M.; Lum, M.L.; Traynelis, S.F.; Kastrup, J.S.; Egebjerg, J. Structural determinants of agonist-specific kinetics at the ionotropic glutamate receptor 2. Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 12053-12058.
115. Hogner, A.; Greenwood, J.R.; Liljefors, T.; Lum, M.L.; Egebjerg, J.; Larsen, I.K.; Gouaux, E.; Kastrup, J.S. Competitive antagonism of AMPA receptors by ligands of different classes: crystal structure of ATPO bound to the GluR2 binding core, in comparison with DNQX. J. Med. Chem., 2003, 46, 214-221.
116. Armstrong, N.; Mayer, M.; Gouaux, E. Tuning activation of the AMPA sensitive GluR2 ion channel by genetic adjustment of agonist- induced conformational changes. Proc. Natl. Acad. Sci. U.S.A., 2003, 100, 5736-5741.
117. Armstrong, N.; Gouaux, E. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron, 2000, 28, 165-181.
118. Hogner, A.; Kastrup, J.S.; Jin, R.; Liljefors, T.; Mayer, M.L.; Egebjerg, J.; Larsen, I.K.; Gouaux, E. Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core. J. Mol. Biol., 2002, 322, 93-109.
119. Kasper, C.; Lum, M.-L.; Liljefors, T.; Gouaux, E.; Egebjerg, J.; Kastrup, J.S. GluR2 ligand-binding core complexes: importance of isooxazol moiety and 5-substituent for the binding mode of AMPA-type agonists. FEBS Lett., 2002, 531, 173-178.
120. Vogensen, S.B.; Frydenvang, K.; Greenwood, J.R.; Postorino, G.; Nielsen, B.; Pickering, D.S.; Ebert, B.; Bolcho, U.; Egebjerg, J.; Gajhede, M.; Kastrup, J.S.; Johansen, T.N.; Clausen, R.P.; Krogsgaard- Larsen, P. A tetrazolyl-substituted subtype-selective AMPA receptor agonist. J. Med. Chem., 2007, 50, 2408-2414.
121. Beich-Frandsen, M.; Pickering, D.S.; Mirza, O.; Johansen, T.N.; Greenwood, J.; Vestergaard, B.; Schousboe, A.; Gajhede, M.; Liljefors, T.; Kastrup, J.S. Structures of the ligand-binding core of iGluR2 in complex with the agonists (R)- and (S)-2-amino-3-(4- hydroxy-1,2,5-thiadiazol-3-yl)propionic acid explain their unusual equipotency. J. Med. Chem., 2008, 51, 1459-1463.
122. Nielsen, A.B.; Pichering, D.S.; Greenwood, J.R.; Brehm, L.; Gajhede, M.; Schousboe, A.; Kastrup, J.S. Exploring the GluR2 ligand-binding core with the bicyclal AMPA analogue (S)-4- AHCP. FEBS J., 2005, 272, 1639-1648.
123. Holm, M.M.; Naur, P.; Vestergaard, B.; Geballe, M.T.; Gajhede, M.; Kastrup, J.S.; Traynelis, S.F.; Egebjerg, J. A binding site tyrosine shapes desensitization kinetics and agonist potency at GluR2: a mutagenic kinetic and crystallographic study. J. Biol. Chem., 2005, 280, 35469-35476.
124. Sun, Y.; Olson, R.; Horning, M.; Armstrong, N.; Mayer, M.; Gouaux, E. Mechanism of glutamate receptor desensitization. Nature, 2002, 417, 245-253.
125. Frandsen, A.; Pichering, D.S.; Vestergaard, B.; Kasper, C.; Nielsen, B.B.; Greenwood, J.R.; Campiani, G.; Fattorusso, C.; Gajhede, M.; Schousboe, A.; Kastrup, J.S. Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2. Mol. Pharmacol., 2005, 67, 703-713.
126. Armstrong, N.; Sun, Y.; Chen, G.Q.; Gouaux, E. Structure of a glutamate receptor ligand-binding core in complex with kainate. Nature, 1998, 395, 913-917.
127. Zhang, W.; Cho, Y.; Lolis, E.; Howe, J.R. Structural and singlechannel results indicate that the rates of ligand binding domain closing and opening directly impact AMPA receptor gating. J. Neurosci., 2008, 28, 932-943.
128. Ahmed, A.H.; Wang, Q.; Sondermann, H.; Oswald, R.E. Structure of the S1S2 glutamate binding domain of GLUR3. Proteins, 2009, 75, 628-637.
129. Hald, H.; Ahring, P.K.; Timmermann, D.B.; Liljefors, T.; Gajhede, M.; Kastrup, J.S. Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2. J. Mol. Biol., 2009, 391, 906-917.
130. Kasper, C.; Pickering, D.S.; Mirza, O.; Olsen, L.; Kristensen, A.S.; Greenwood, J.R.; Liljefors, T.; Schousboe, A.; Watjen, F.; Gajhede, M.; Sigurskjold, B.W.; Kastrup, J.S. The structure of a mixed GluR2 ligand-binding core dimer in complex with (S)- glutamate abd the antagonist (S)-NS1209. J. Mol. Biol., 2006, 357, 1184-201.
131. Ahmad, A.H.; Oswald, R.E. Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4- isoxazole-propionic acid (AMPA) receptors. J. Med. Chem., 2010, 53, 2197-2203.
132. Ahmed, A.H.; Ptak, C.P.; Oswald, R.E. Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA. Biochemistry, 2010, 49, 2843-2850.
133. Ptak, C.P.; Ahmed, A.H.; Oswald, R.E. Probing the allosteric modulator binding site of GluR2 with thiazide derivatives. Biochemistry 2009, 48, 8594-8602.
134. Kaae, B.H.; Harpsoe, K.; Kastrup, J.S.; Sanz, A.C.; Pickering, D.S.; Metzler, B.; Clausen, R.P.; Gajhede, M.; Sauerberg, P.; Liljefors, T.; Madsen, U. Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites. Chem. Biol., 2007, 14, 1294-1303.
135. Jin, R.; Horning, M.; Mayer, M.L.; Gouaux, E. Mechanism of activation and selectivity in a ligand-gated ion channel. Structural and functional studies of GluR2 and quisqualate. Biochemistry, 2002, 41, 15635-41563.
136. Jin, R.; Clark, S.; Weeks, A.M.; Dudman, J.T.; Gouaux, E.; Partin, K.M. Mechanism of positive allosteric modulators acting on AMPA receptors. J. Neurosci. 2005, 25, 9027-9036.
137. Jin, R.; Banke, T.G.; Mayer, M.L.; Traynelis, S.F.; Gouaux, E. Structural basis for partial agonist action at ionotropic glutamate receptors. Nat. Neurosci., 2003, 6, 803-810.
138. Jin, R.; Gouaux, E. Probing the function, conformational plasticity and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardines and GluR2 S1S2 in the crystal. Biochemistry, 2003, 42, 5201-5213.
139. Ahmed, A.H.; Thompson, M.D.; Fenwick, M.K.; Romero, B.; Loh, A.P.; Jane, D.E.; Sondermann, H.; Oswald, R.E. Mechanisms of antagonism of the GluR2 AMPA receptor: structure and dynamics of the complex of two willardiine antagonists with the glutamate binding domain. Biochemistry, 2009, 48, 3894-3903.
140. Menuz, K.; Stroud, R.M.; Nicoll, R.A.; Hays, F.A. TARP auxiliary subunits switch AMPA receptor antagonists into partial agonists. Science, 2007, 318, 815-817.
141. Cruz, L.A.; Estebanez-Perpina, E.; Pfaff, S.; Borngraeber, S.; Bao, N.; Blethrow, J.; Fletterick, R.J.; England, P.M. 6-Azido-7-nitro- 1,4-dihydroquinoxaline-2,3-dione (ANQX) forms an irreversible bond to the active site of the GluR2 AMPA receptor. J. Med. Chem., 2008, 51, 5856-5860.
142. Armstrong, N.; Jasti, J.; Beich-Frandsen, M.; Gouaux, E. Measurement of conformational changes accompanying desensitization in ionotropic glutamate receptor. Cell, 2006, 127, 85-97.
143. Greger, I.H.; Akamine, P.; Khatri, L.; Ziff, E.B. Developmentally regulated, combinatorial RNA processing modulates AMPA receptor biogenesis. Neuron, 2006, 51, 85-97.
144. Weston, M.C.; Gertler, C.; Mayer, M.L.; Rosenmund, C. Interdomain interactions in AMPA and kainate receptors regulate affinity for glutamate. J. Neurosci., 2006, 26, 7650-7658.
145. Kasper, C.; Frydenvang, K.; Naur, P.; Gajhede, M.; Pickering, D.S.; Kastrup, J.S. Molecular mechanism of agonist recognition by the ligand-binding core of the ionotropic glutamate receptor 4. FEBS Lett., 2008, 582, 4089-4094.
146. Birdsey-Benson, A.; Gill, A.; Henderson, L.P.; Madden, D.R. Enhanced efficacy without further cleft closure: reevaluating twist as a source of agonist efficacy in AMPA receptors. J. Neurosci., 2010, 30, 1463-1470.
147. Gill, A.; Birdsey-Benson, A.; Jones, B.L.; Henderson, L.P.; Madden, D.R. Correlating AMPA receptor activation and cleft closure across subunits: crystal structures of the GluR4 ligand-binding domain in complex with full and partial agonists. Biochemistry, 2008, 47, 13831-13841.
148. Mayer, M.L. Crystal structures of the GluR5 and GluR6 ligand binding cores. Molecular mechanisms underlying kainate receptor selectivity. Neuron, 2005, 45, 539-552.
149. Naur, P.; Vestergaard, B.; Skov, L.K.; Egebjerg, J.; Gajhede, M.; Kastrup, J.S. Crystal structure of the kainate receptor GluR5 binding core in complex with (S)-glutamate. FEBS Lett., 2005, 579, 1154-1160.
150. Mayer, M.L.; Ghosal, A.; Dolman, N.P.; Jane, D.E. Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists. J. Neurosci., 2006, 26, 2852- 2861.
151. Unno, M.; Shinohara, M.; Takayama, K.; Teruya, K.; Dohura, K.; Sakai, R.; Sasaki, M.; Ikeda-Saito, M. Crystal structures of human GluR5 ligand-binding core in complexes with marine-derived toxins, dysiherbaine and neodysiherbaine A, and their synthetic analogues. Unpublished results.
152. Frydenvang, K.; Lash, L.L.; Naur, P.; Postila, P.A.; Pickering, D.S.; Smith, C.M.; Gajhede, M.; Sasaki, M.; Sakai, R.; Pentikaïnen, O.T.; Swanson, G.T.; Kastrup, J.S. Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high affinity agonist dysiherbaine and the functional antagonist 8,9-dideoxyneodysiherbaine. J. Biol. Chem., 2009, 284, 14219-14229.
153. Alushin, G.M.; Jane, D.E.; Mayer, M.L. Crystal structure of the GluR5 ligand binding core dimer in complex with UBP315 at 1.80 Angstroms resolution. Unpublished results.
154. Alushin, G.M.; Jane, D.E.; Mayer, M.L. Crystal structure of the GluR5 ligand binding core dimer in complex with UBP316 at 1.76 Angstroms resolution. Unpublished results.
155. Alushin, G.M.; Jane, D.E.; Mayer, M.L. Crystal structure of the GluR5 ligand binding core dimer in complex with UBP318 at 1.80 Angstroms resolution. Unpublished results.
156. Hald, H.; Naur, P.; Pickering, D.S.; Sprogoe, D.; Madsen, U.; Timmermann, D.B.; Ahring, P.K.; Liljefors, T.; Schousboe, A.; Egebjerg, J.; Gajhede, M.; Kastrup, J.S. Partial agonism and antagonism of the ionotropic glutamate receptor iGLuR5: structures of the ligand-binding core in complex with domoic acid and 2- amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid. J. Biol. Chem., 2007, 282, 25726-25736.
157. Alushin, G.M.; Jane, D.E.; Mayer, M.L. Crystal structure of the GluR5 ligand binding core dimer in complex with LY466195 at 1.58 Angstroms resolution. Unpublished results.
158. Clausen, R.P.; Naur, P.; Kristensen, A.S.; Greenwood, J.R.; Strange, M.; Bräuner-Osborne, H.; Jensen, A.A.; Nielsen, A.S.; Geneser, U.; Ringgaard, L.M.; Nielsen, B.; Pickering, D.S.; Brehm, L.; Gajhede, M.; Krogsgaard-Larsen, P.; Kastrup, J.S. The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8- dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8- methyl analogue: synthesis, molecular pharmacology, and biostructural characterization. J. Med. Chem. 2009, 52, 4911-4922.
159. Plested, A.J.; Vijayan, R.; Biggin, P.C.; Mayer, M.L. Molecular basis of kainate receptor modulation by sodium. Neuron, 2008, 58, 720-735.
160. Plested A.J.; Mayer, M.L. Structure and mechanism of kainate receptor modulation by anions. Neuron, 2007, 53, 829-841.
161. Chaudhry, C.; Weston, M.C.; Schuck, P.; Rosenmund, C.; Mayer, M.L. Stability of ligand-binding domain dimer assembly controls kainate receptor desensitization. EMBO J. 2009, 28, 1518-1530.
162. Nanao, M.H.; Green, T.; Stern-Bach, Y.; Heinemann, S.F.; Choe, S. Structure of the kainate receptor subunit GluR6 agonist binding domain complexed with domoic acid. Proc. Natl. Acad. Sci. U.S.A., 2005, 102, 1708-1713.
163. Weston, M.C.; Schuck, P.; Ghosal, A.; Rosenmund, C.; Mayer, M.L. Conformational restriction blocks glutamate receptor desensitization. Nat. Struct. Mol. Biol., 2006, 13, 1120-1127.
164. Mayer, M.L.; Olson, R.; Gouaux, E. Mechanisms for ligand binding to GluR0 ion channels: crystal structures of the glutamate and serine complexes and a closed apo state. J. Mol. Biol. 2001, 311, 815-836.
165. Horning, M.S.; Mayer, M.L. Regulation of AMPA receptor gating by ligand binding core dimers. Neuron 2004, 41, 379-388.
166. Erreger, K.; Chen, P.E.; Wyllie, D.J.A.; Traynelis, S.F. Glutamate receptor gating. Crit. Rev. Neurobiol., 2004, 16, 187-224.
167. Nyikos, L.; Simon, A.; Barábas, P.; Kardos, J. Ligand-specific conformations of an ionotropic glutamate receptor. Prot. Eng. 2002, 15, 717-720.
168. Madden, DR.; Armstrong, N.; Svergun, D.; Perez, J.; Vachette, P. Solution X-ray scattering evidence for agonist- and antagonistinduced modulation of cleft closure in a glutamate receptor ligandbinding domain. J. Biol. Chem., 2005, 280, 23637-23642.
169. Jansen, M.; Dannhardt, G. Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions. Eur. J. Med. Chem., 2003, 38, 661-670.
170. Morrow, J.A.; Maclean, J.K.F.; Jamieson, C. Recent advances in positive allosteric modulators of the AMPA receptor. Curr. Opin. Drug Discov. Devel., 2006, 9, 571-579.
171. Zhang, Y.; Nayeem, N.; Nanao, M.H.; Green, T. Interface interactions modulating desensitization of the kainate-selective ionotropic glutamate receptor subunit GluR6. J. Neurosci., 2006, 26, 10033- 10042.
172. Fleck, M.W.; Cornell, E.; Moch, S.J. Amino acid residues involved in glutamate receptor 6 gating and desensitization. J. Neurosci., 2003, 23, 1219-1227.
173. Fay, A.-M.L.; Bowie, D. Concavalin-A reports agonist-induced conformational changes in the intact GluR6 kainate receptors. J. Physiol., 2006, 572, 201-213.
174. Francotte, P.; Goffin, E.; Fraikin, P.; Lestage, P.; Van Heugen, J.C.; Gillotin, F.; Danober, L.; Thomas, J.Y.; Chiap, P.; Caignard, D.H.; Pirotte, B.; de Tullio, P. New fluorinated 1,2,4- benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3- hydroxy-5-methylisoxazol-4-yl)propionic acid receptors. J. Med. Chem., 2010, 53, 1700-1711.
175. + sensitivity of excitatory amino acid receptor channels in rat cerebellar granule neurons. J. Physiol., 1991, 433, 727-763.
176. Lei, S.; Orser, B.A.; Thatcher, G.R.; Reynolds, J.N.; MacDonald, J.F. Positive allosteric modulators of AMPA receptors reduce proton- induced receptor desensitization in rat hippocampal neurons. J. Neurophysiol., 2001, 85, 2030-2038.
177. McDonald, J.W.; Bhattacharyya, T.; Sensi, S.L.; Lobner, D.; Ying, H.S.; Canzoniero, L.M.; Choi, D.W. Extracellular acidity potentiates AMPA receptor-mediated cortical neuronal death. J. Neurosci., 1998, 18, 6290-629
178. Belenikin, M.S.; Baskin, I.I.; Constantino, G.; Palyulin, V.A.; Pellicciari, R.; Zefirov, N.S. Molecular modeling of the closed forms of the kainate-binding domains of kainate receptors and qualitative analysis of the structure-activity relationships for some agonists. Dokl. Biochem. Biophys. 2002, 386, 239-44.
179. Grazioso, G.; Moretti, L.; Scapozza, L.; De Amici, M.; De Micheli, C. Development of a three-dimensional model for the N-methyl-Daspartate NR2A subunit. J. Med. Chem., 2005, 48, 5489-5494.
180. Mendieta, J.; Ramirez, G.; Gago, F. Molecular dynamics simulations of the glutamate receptor ligand-binding core in the presence of glutamate and kainate. Proteins, 2001, 44, 460-469.
181. Arinaminpathy, Y.; Sansom, M.S.P.; Biggin, P.C. Molecular dynamics simulations of the ligand-binding domain of the ionotropic glutamate receptor GluR2. Biophys. J., 2002, 82, 676-683.
182. Pang, A.; Arinaminpathy, Y.; Sansom, M.S.P.; Biggin, P.C. Interdomain dynamics and ligand binding: molecular dynamics simulation of glutamine binding protein. FEBS Lett., 2003, 550, 168-174.
183. Kaye, S.L.; Sansom, M.S.P.; Biggin, P.C. Molecular dynamics simulations of the ligand-binding domain of an N-methyl-Daspartate receptor. J. Biol. Chem., 2006, 281, 12736-12742.
184. Mamonova, T.; Speranskiy, K.; Kurnikova, M. Interplay between structural rigidity and electrostatic interactions in the ligand binding domain of GluR2. Proteins, 2008, 73, 656-671.
185. Postila, P.A.; Swanson, G.T.; Pentikäinen, O.T. Exploring kainate receptor pharmacology using molecular dynamics simulations. Neuropharmacology, 2010, 58, 515-527.
186. Roche, K.W.; Raymond, L.A.; Blackstone, C; Huganir, R.L. Transmembrane topology of the glutamate receptor subunit GluR6. J. Biol. Chem., 1994, 269, 11679-11682.
187. Beck, C.; Wollmuth, L.P.; Seeburg, P.H.; Sakmann, B. NMDAR channel segments forming the extracellular vestibule inferred from the accessibility of substituted cysteines. Neuron, 1999, 22, 559- 570.
188. Kuner, T.; Wollmuth, L.P.; Karlin, A.; Seeburg, P.H.; Sakmann, B. Structure of the NMDA receptor channel M2 segment inferred from the accessibility of substituted cysteines. Neuron, 1996, 17, 343-352.
189. Sobolevsky, A.I. Insight into structure and function of ionotropic glutamate receptor channels: starting from channel block. Biochemistry (Moscow) Supplement Series A: Mebrane Cell Biol., 2007, 1, 45-56.
190. Zarei, M.M.; Dani, J.A. Structural basis for explaining openchannel blockade of the NMDA receptor. J. Neurosci., 1995, 15, 1446-1454.
191. Villarroel, A.; Burnashev, N.; Sakman, B. Dimensions of the narrow portion of a recombinant NMDA receptor channel. Biophys. J., 1995, 68, 866-875.
192. Wollmuth, L.P.; Kuner, T.; Seeburg, P.H.; Sakman, B. Differerential contribution of the NR1 and NR2A-subunits to the selectivity filter of recombinant NMDA receptor channels. J. Physiol., 1996, 491, 779-97.
193. Burnashev, N.; Villarroel, A.; Sakman, B. Dimensions and ion selectivity of recombinant AMPA and kainate receptors and their dependence o Q/R site residues. J. Physiol., 1996, 496, 165-173.
194. Sobolevsky, A.J.; Koshelev, S.G.; Khodorov, B.I. Probing of NMDA channels with fast blockers. J. Neurosci., 1999, 19, 10611- 10626.
195. Sobolevsky, A.I.; Koshelev, S.G.; Khodorov, B.I. Molecular size and hydrophobicity as factors which determine the efficacy and the blocking action of amino-adamantane derivatives on NMDA channels. Membr. Cell Biol., 1999, 13, 79-93.
196. Sobolevsky, A.I. Quantitative analysis of tetrapentylammoniuminduced blockade of open N-methyl-D-aspartate channels. Biophys. J., 2000, 79, 1324-1335.
197. Panchenko, V.A.; Glasser, C.R.; Mayer, M.L. Structural similarities between glutamate receptor channels and K(+) channels examined by scanning mutagenesis. J. Gen. Physiol., 2001, 117, 345- 360.
198. Wollmuth, L.P.; Sobolevsky, A.I. Structure and gating of te glutamate receptor ion channel. Trends Neurosci., 2004, 27, 321-8.
199. Kuner, T.; Seeburg, P.H.; Guy, H.R. A common architecture for K+ channels and ionotropic glutamate receptors? Trends Neurosci., 2003, 26, 27-32.
200. Liu, Y.; Holmgren, M.; Jurman, M.E.; Yellen, G. Gated access to the pore of a voltage-dependent K+ channel. Neuron, 1997, 19, 175-184.
201. del Camino, D.; Yellen, G. Tight steric closure at the intracellular activation of a voltage-gated K+ channel. Neuron, 2001, 32, 649- 656.
202. Sobolevsky, A.I.; Yelshansky, M.V.; Wollmuth, L.P. Different gating mechanisms in glutamate receptor and K+ channels. J. Neurosci., 2003, 23, 7559-7568.
203. Jiang Y.; Lee, A.; Chen, J.; Cadene, M.; Chait, B.T.; MacKinnon, R. The open pore conformation of potassium channels. Nature, 2002, 417, 523-526.
204. Jones, K.S.; Van Dongen, H.M.; Van Dongen, A.M. The NMDA receptor M3 segment is a conserved transduction elemnet coupling ligand binding to channel opening. J. Neurosci., 2002, 22, 2044- 2053.
205. Sobolevsky, A.I.; Beck, C.; Wollmuth, L.P. Molecular rearrangements of the extracellular vestibule in NMDAR channels during gating. Neuron, 2002, 33, 75-85.
206. 2+ flux rates in NMDA receptor channels. J. Neurosci., 2002, 22, 10209-10216.
207. Yuan, H.; Erreger, K.; Dravid, S.M.; Traynelis, S.F. Conserved structural and functional control of N-methyl-D-aspartate receptor gating by transmembrane domain M3. J. Biol. Chem., 2005, 280, 29708-29716.
208. Hoffmann, J.; Villmann, C.; Werner, M.; Hollmann, M. Investigation via ion pore transplantaion of the putative relationship between glutamate receptors and K+ channels. Mol. Cell Neurosci., 2006, 33, 358-370.
209. Sobolevsky, A.I.; Prodromou, M.L.; Yelshansky, M.V.; Wollmuth, L.P. Subunit-specific contribution of pore-forming domains to NMDA receptor channel structure and gating. J. Gen. Physiol., 2007, 129, 509-525.
210. Bertaccini, E.; Trudell, J.R. Molecular modeling of ligand-gated ion channels: progress and challenges. Int. Rev. Neurobiol., 2001, 48, 141-166.
211. Tikhonov, D.B.; Mellor, J.R.; Usherwood, P.N.R.; Magazanik, L.G. Modeling of the pore domain of the GLUR1 channel: homology with K+ channel and binding of channel blockers. Biophys. J., 2002, 82, 1884-1893.
212. Tikhonova, I.G.; Baskin, I.I.; Palyulin, V.A.; Zefirov, N.S. 3Dmodel of the ion channel of NMDA receptor: qualitative and quantitative modeling of the blocker binding. Dokl. Biochem. Biophys., 2004, 396, 551-556.
213. Goychuk, I.; Hanggi, P.; Vega, J.L.; Miret-Artes, S. Non- Markovian stochastic resonance: three-state model of ion channel gating. Phys. Rev. E, 2005, 71, 061906.
214. Tikhonov, D.B. Ion channels of glutamate receptors: structural modeling. Mol. Memb. Biol., 2007, 24, 135-147.
215. Ren, H.; Honse, Y.; Karp, B.J.; Lipsky, R.H.; Peoples, R.W. A site in the fourth membrane-associated domain of the N-methyl-Daspartate receptor regulates desensitization and ion channel gating. J. Biol. Chem., 2003, 278, 276-283.
216. Thomas, C.G.; Krupp, J.J.; Bagley, E.E.; Bauzon, R.; Heinemann, S.F.; Vissel, B.; Westbrook, G.L. Probing N-methyl-D-aspartate receptor desensitization with the substituted-cysteine accessibility method. Mol. Pharmacol., 2006, 69, 1296-1303.
217. Low C.M.; Lyuboslavsky, P.; French, A.; Le, P.; Wyatte, K.; Thiel, W.H.; Marchan, E.M.; Igarashi, K.; Kashiwagi, K.; Gernert, K.; Williams, K.; Traynelis, S.F.; Zheng, F. Molecular determinants of proton-sensitive N-methyl-D-aspartate receptor gating. Mol. Pharmacol., 2003, 63, 1212-1222.
218. Yelshansky, M.V.; Sobolevsky, A.I.; Jatzke, C.; Wollmuth, L.P. Block of AMPA receptor desensitization by a point mutation outside the ligand-binding domain. J. Neurosci., 2004, 24, 4728-4736.
219. Speranskiy, K.; Kurnikova, M.G. Modeling of peptides connecting the ligand binding and transmembrane domains in the GluR2 glutamate receptor. Proteins: Str. Funct. Bioinf., 2008, 76, 271-280.
220. Mohrmann, R.; Kohr, G.; Hatt, H.; Sprengel, R.; Gottmann, K. Deletion of the C-terminal domain of the NR2B receptor subunit alters channel properties and synaptic targeting of N-methyl-Daspartate receptors in nascent neocortical synapses. J. Neurosci. Res., 2002, 68, 265-275.
221. Beresewicz, M. Scaffold proteins (MAGUK, Shank and Homer) in postsynaptic density in the central nervous system. Postłpy Biochem., 2007, 53, 188-197.
222. Zheng, C.Y.; Petralia, R.S.; Wang, Y.X.; Kachar, B.; Wenthold, R.J. SAP102 is a highly mobile MAGUK in spines. J. Neurosci., 2010, 30, 4757-4766.
223. Zhang, J.; Diamond, J.S. Subunit- and pathway-specific localization of NMDA receptors and scaffolding proteins at ganglion cell synapses in rat retina. J. Neurosci., 2009, 29, 4274-4286.
224. Boeckers, T.M.; Bockmann, J.; Kreutz, M.R.; Gundelfinger, E.D. ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J. Neurochem., 2002, 81, 903-910.
225. Bertaso, F.; Roussignol, G.; Worley, P.; Bockaert, J.; Fagni, L.; Ango, F. Homer1a-dependent crosstalk between NMDA and metabotropic glutamate receptors in mouse neurons. PLoS One, 2010, 5, e9755.
226. Missale, C.; Fiorentini, C.; Busi, C.; Collo, G.; Spano, P.F. The NMDA/D1 receptor complex as a new target in drug development. Curr. Top. Med. Chem., 2006, 6, 801-808.
227. Pei, L.; Lee, F.J.; Moszczynska, A.; Vukusic, B.; Liu, F. Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. J. Neurosci., 2004, 24, 1149-1158.
228. Nai, Q.; Li, S.; Wang, S.H.; Liu, J.; Lee, F.J.; Frankland, P.W.; Liu, F. Uncoupling the D1-N-methyl-D-aspartate (NMDA) receptor complex promotes NMDA-dependent long-term potentiation and working memory. Biol. Psychiatry, 2010, 67, 246-254.
229. Bowie, D. External anions and cations distinguish between AMPA and kainate receptor gating mechanisms. J. Physiol., 2002, 539, 725-733.
230. Wong, A.Y.; Fay, A.M.; Bowie, D. External ions are coactivators of kainate receptors. J. Neurosci., 2006, 26, 5750-5755.
231. Wong, A.Y.; MacLean, D.M.; Bowie, D. Na+/Cl- dipole couples agonist binding to kainate receptor activation. J. Neurosci., 2007, 27, 6800-6809.
232. Mott, D.D.; Benveniste, M.; Dingledine, R.J. pH-dependent inhibition of kainate receptors by zinc. J. Neurosci., 2008, 28, 1659- 1671.
233. 2+ permeability of AMPARs at cerebellar synapses. Nat. Neurosci., 2005, 8, 768-775.
234. Gardner, S.M.; Takamiya, K.; Xia, J.; Suh, J.G.; Johnson, R.; Yu, S.; Huganir, R.L. Calcium-permeable AMPA receptor plasticity is mediated by subunit-specific interactions with PICK1 and NSF. Neuron, 2005, 45, 903-915.
235. Hanley, J.G. PICK1: a multi-talented modulator of AMPA receptor trafficking. Pharmacol. Ther., 2008, 118, 152-160.
236. Priel, A.; Kolleker, A.; Ayalon, G.; Gillor, M.; Osten, P.; Stern-Bach, Y. Stargazin reduces desensitization and slows deactivation of the AMPA-type glutamate receptors. J. Neurosci., 2005, 25, 2682-2686.
237. Sager, C.; Tapken, D.; Kott, S.; Hollmann, M. Functional modulation of AMPA receptors by transmembrane AMPA receptor regulatory proteins. Neuroscience, 2009, 158, 45-54.
238. Turetsky, D.; Garringer, E.; Patneau, D.K. Stargazin modulates native AMPA receptor functional properties by two distinct mechanisms. J. Neurosci., 2005, 25, 7438-7448.
239. Cokił, B.; Stein, V. Stargazin modulates AMPA receptor antagonism. Neuropharmacology, 2008, 54, 1062-1070.
240. Sobolevsky, A.I.; Yelshansky, M.V.; Wollmuth, L.P. The outer pore of the glutamate receptor channel has 2-fold rotational symmetry. Neuron 2004, 41, 367-378.
241. DeLano, W. L. The PyMOL Molecular Graphics System, DeLano Scientific, San Carlos, CA, USA, 2002.
242. Krieger, E.; Vriend, G. Models@Home - Distributed Computing in Bioinformatics Using a Screensaver Based Approach. Bioinformatics, 2002, 18, 315-318.
243. Pedretti, A.; Villa, L.; Vistoli, G. J. VEGA - an Open Platform to Develop Chemo-Bio-Informatics Applications, Using Plug-In Architecture and Script Programming. J. Comput.-Aided Mol. Des., 2004, 18, 167-173.
244. Pettersen, E.F.; Goddard, T.D.; Huang, C.C.; Couch, G.S.; Greenblatt, D.M.; Meng, E.C.; Ferrin, T.E. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem., 2004, 25, 1605-1612.
245. Guex, N.; Peitsch, M.C. SWISS-MODEL and the Swiss-Pdb viewer: An environment for comparative protein modeling. Electrophoresis, 1997, 18, 2714-2723.